AddLife Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

AddLife şirketinin toplam hissedar öz sermayesi SEK5.2B ve toplam borcu SEK5.3B olup, bu da borç-öz sermaye oranını 102.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla SEK13.3B ve SEK8.1B dir. AddLife 'in FAVÖK'ü SEK492.0M faiz karşılama oranı -2.5 dur. Şirketin SEK229.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

95.9%

Borç/özkaynak oranı

SEK 4.92b

Borç

Faiz karşılama oranı	2.2x
Nakit	SEK 264.00m
Eşitlik	SEK 5.13b
Toplam yükümlülükler	SEK 7.81b
Toplam varlıklar	SEK 12.94b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: ALIFBS 'nin kısa vadeli varlıkları ( SEK3.8B ) kısa vadeli yükümlülüklerini ( SEK3.2B ) aşıyor.

Uzun Vadeli Yükümlülükler: ALIFBS 'un kısa vadeli varlıkları ( SEK3.8B ) uzun vadeli yükümlülüklerini ( SEK4.6B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: ALIFBS 'nin net borç/öz sermaye oranı ( 97.7% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: ALIFBS şirketinin borç/öz sermaye oranı son 5 yılda 79.8% seviyesinden 102.1% seviyesine yükseldi.

Borç Kapsamı: ALIFBS 'nin borcu işletme nakit akışı ( 12.8% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: ALIFBS 'in borcuna ilişkin faiz ödemeleri EBIT ( 1.8 x kapsam) tarafından iyi karşılanmıyor.

AddLife Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

AddLife AB (publ) to Report First Half, 2025 Results on Jul 15, 2025

AddLife AB (publ) to Report Q1, 2025 Results on Apr 25, 2025

AddLife AB (publ) Approves Dividend, Payable on 16 May 2024

AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025

AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024

AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024

AddLife AB (publ), Annual General Meeting, May 08, 2024

Second quarter 2023 earnings released: EPS: kr0.27 (vs kr0.61 in 2Q 2022)

Independent Director recently bought kr12m worth of stock

Investor sentiment improves as stock rises 37%

President & CEO recently bought kr129k worth of stock

Addlife AB (Publ) Declares Dividend

Upcoming dividend of kr1.20 per share at 1.0% yield

President & CEO recently bought kr139k worth of stock

President & CEO recently bought kr112k worth of stock

AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022

President & CEO recently bought kr285k worth of stock

Håkan Roos acquired a 0.246285% stake in AddLife AB (publ) for SEK 30 million.

AddLife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023

AddLife AB (publ) to Report Q1, 2023 Results on Apr 26, 2023

Second quarter 2022 earnings released

Now 23% undervalued after recent price drop

Investor sentiment deteriorated over the past week

CFO & Business Area Manager of Medtech recently sold kr8.5m worth of stock

Addlife AB (Publ) Approves Dividend, Payable on 12 May 2022

AddLife AB (publ) Appoints Fredrik Dalborg as President

Full year 2021 earnings released: EPS: kr6.02 (vs kr4.62 in FY 2020)

AddLife AB (publ) (OM: ALIF B) acquired O'Flynn Medical Limited.

Addlife AB (Publ) Proposes Dividend, Payable on 12 May 2022

Investor sentiment improved over the past week

AddLife AB (publ) (OM:ALIF B) completed the acqusitions of Telia Health Monitoring.

President & CEO recently bought kr5.8m worth of stock

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Addlife AB (Publ) Proposes Dividend

Addlife AB (Publ) Announces Step Down of Kristina Willgård as Chief Executive Officer

AddLife AB (publ) (OM:ALIF B) completed the acquisition of MBA Incorporado S.A from Alantra Private Equity.

Investor sentiment deteriorated over the past week

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire MBA Incorporado S.A from Alantra Private Equity for approximately €110 million.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Telia Health Monitoring.

Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million.

President & CEO recently sold kr32m worth of stock

Third quarter 2021 earnings released

Investor sentiment deteriorated over the past week

Independent Chairman recently sold kr11m worth of stock

AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV.

Investor sentiment improved over the past week

Chief Financial Officer recently sold kr106k worth of stock

Independent Chairman recently sold kr7.0m worth of stock

Second quarter 2021 earnings released: EPS kr1.46 (vs kr1.07 in 2Q 2020)

Investor sentiment improved over the past week

Chief Financial Officer recently sold kr14m worth of stock

Independent Director has left the company

AddLife AB (publ) Approves Dividend, Payable on 12 May 2021

First quarter 2021 earnings released

Upcoming dividend of kr1.50 per share

AddLife AB (Publ) Provides Earnings Guidance for 2021

New 90-day high: kr175

Full year 2020 earnings released: EPS kr4.62 (vs kr1.27 in FY 2019)

New 90-day high: kr169

AddLife AB (publ) to Report Fiscal Year 2021 Results on Feb 03, 2022

New 90-day high: kr150

Insider recently bought kr692k worth of stock

AddLife AB (publ) (OM:ALIF B) completed the acquisition of the advanced surgery business of SIAD Healthcare S.p.A.

AddLife AB (publ) to Report Nine Months, 2021 Results on Oct 22, 2021

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Zafe Care Systems Ab.

AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Ropox A/S.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin